{
  "id": "mrna-technologie",
  "slug": "mrna-technologie",
  "name": "mRNA-Technologie",
  "scientific_name": "Messenger RNA Therapeutics",
  "kingdom": "vaccine-tech",
  "kingdom_icon": "ğŸ’‰",
  "image": null,
  "tagline": "Basis der COVID-19-Impfstoffe",
  "description": "Die mRNA-Technologie nutzt Boten-RNA, um KÃ¶rperzellen zur Produktion spezifischer Proteine anzuleiten. Sie ermÃ¶glichte die schnelle Entwicklung von COVID-19-Impfstoffen und wird fÃ¼r Krebsimmuntherapien erforscht.",
  "seo_description": "mRNA-Technologie - Grundlage moderner Impfstoffe und Therapeutika",
  "quick_facts": [
    {"icon": "ğŸ“…", "label": "COVID-Einsatz", "value": "2020"},
    {"icon": "ğŸ‘©â€ğŸ”¬", "label": "Pioniere", "value": "KarikÃ³ & Weissman"},
    {"icon": "ğŸ†", "label": "Nobelpreis", "value": "Medizin 2023"},
    {"icon": "ğŸ’‰", "label": "Impfungen", "value": "Milliarden weltweit"}
  ],
  "highlights": ["COVID-19-Impfstoffe", "Nobelpreis 2023", "Krebsimmuntherapie"],
  "badges": [
    {"icon": "ğŸ†", "label": "Nobelpreis", "status": "Medizin 2023", "variant": "success"},
    {"icon": "ğŸ¢", "label": "Firmen", "status": "BioNTech & Moderna", "variant": "info"}
  ],
  "categories": ["Impfstofftechnologie", "Therapeutika"],
  "keywords": ["mrna", "impfstoff", "biontech", "moderna", "covid", "immuntherapie"],
  "perspectives": ["methodology", "products", "applications_biotech", "regulation", "future"],
  "perspective_count": 5,
  "engagement_score": 96,
  "_sources": {"image": [], "fields": {}}
}
